Using basic science to design a clinical trial: baseline characteristics of women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS)
about
Timing and duration of menopausal hormone treatment may affect cardiovascular outcomesEffects of Hormone Therapy on Cognition and Mood in Recently Postmenopausal Women: Findings from the Randomized, Controlled KEEPS-Cognitive and Affective StudyAlzheimer's disease, dementia, mild cognitive impairment and the menopause: a 'window of opportunity'?Premature menopause and risk of neurological disease: basic mechanisms and clinical implicationsYes! Sex matters: sex, the brain and blood pressure.Continuous and cyclic progesterone differentially interact with estradiol in the regulation of Alzheimer-like pathology in female 3xTransgenic-Alzheimer's disease mice.Effects of different hormone therapies on breast pain in recently postmenopausal women: findings from the Mayo Clinic KEEPS breast pain ancillary studyMenopausal hormone therapy is associated with having high blood pressure in postmenopausal women: observational cohort studyEstrogen, vascular estrogen receptor and hormone therapy in postmenopausal vascular disease.Differences in regional brain metabolism associated with specific formulations of hormone therapy in postmenopausal women at risk for AD.Skin wrinkles and rigidity in early postmenopausal women vary by race/ethnicity: baseline characteristics of the skin ancillary study of the KEEPS trialHormonal influences on cognition and risk for Alzheimer's disease.Congress on women's health Trudy Bush lecture 2014: new insights into sex Hormones and Cardiovascular diseaseCharacterization of vascular disease risk in postmenopausal women and its association with cognitive performance.Estrogen, hormonal replacement therapy and cardiovascular disease.Impact of continuous versus discontinuous progesterone on estradiol regulation of neuron viability and sprouting after entorhinal cortex lesion in female rats.Measurement of estradiol, estrone, and testosterone in postmenopausal human serum by isotope dilution liquid chromatography tandem mass spectrometry without derivatization.Postmenopausal hormone therapy and breast cancer risk: current status and unanswered questions.The KEEPS-Cognitive and Affective Study: baseline associations between vascular risk factors and cognitionImplications for reproductive medicine: Sex differences in cardiovascular diseaseSex-specific immune modulation of primary hypertension.Endothelial function in women of the Kronos Early Estrogen Prevention Study.Alterations in platelet function and cell-derived microvesicles in recently menopausal women: relationship to metabolic syndrome and atherogenic risk.Vascular effects of estrogenic menopausal hormone therapy.Loss of receptor activity-modifying protein 3 exacerbates cardiac hypertrophy and transition to heart failure in a sex-dependent manner.One more look at guidelines for primary and secondary prevention of cardiovascular disease in women.Genetics of cardiovascular disease: Importance of sex and ethnicity.Estrogen neuroprotection and the critical period hypothesis.Strategies and methods to study sex differences in cardiovascular structure and function: a guide for basic scientists.Aging, Angiotensin system and dopaminergic degeneration in the substantia nigra.Estrogen and Cardiovascular Disease: Is Timing Everything?Comparison of calibrated and uncalibrated bone mineral density by CT to DEXA in menopausal women.Prognostic factors in paediatric anaplastic large cell lymphoma: role of ALK.Longitudinal effects of menopausal hormone treatments on platelet characteristics and cell-derived microvesicles.Genetic polymorphisms associated with carotid artery intima-media thickness and coronary artery calcification in women of the Kronos Early Estrogen Prevention StudyBrain angiotensin and dopaminergic degeneration: relevance to Parkinson's diseaseEffects of estrogen with micronized progesterone on cortical and trabecular bone mass and microstructure in recently postmenopausal womenPharmacogenomics of estrogens on changes in carotid artery intima-medial thickness and coronary arterial calcification: Kronos Early Estrogen Prevention Study.Specific cell-derived microvesicles: Linking endothelial function to carotid artery intima-media thickness in low cardiovascular risk menopausal women.Self-reported menopausal symptoms, coronary artery calcification, and carotid intima-media thickness in recently menopausal women screened for the Kronos early estrogen prevention study (KEEPS)
P2860
Q24626206-C6E6844F-EB3E-4742-A614-A1E3787A1C5DQ28547748-FFC2EA58-D13E-4D8A-883E-49D4A3340FB9Q30620862-843A3AA8-824A-40DF-963D-5B48B13A4B6FQ33693151-BA19DB02-FA8A-4B88-8DB5-A78CC80C527AQ33844368-AAAD14CD-E1CB-4214-9571-208525B357DCQ33874451-92E75AAA-2C89-4281-AF35-CF65CC3B95BDQ34330784-6DF328EE-6EFC-472D-9B89-B8F33FDBCE75Q34341907-D0845E50-DACB-415B-84CE-1ADF25DC290BQ34375771-AC60F0E5-E7AD-4156-B687-56D8F37EDA0FQ34494238-AB06E6C9-36DB-4839-B942-4570EBCD30E7Q34516796-31EDF3FE-703D-4507-8E82-4BFD1A8C96F9Q34680911-5869A5F7-5E9E-4D70-A546-E72612117CC5Q34707823-0BBD6A4A-6A5C-4915-80D6-F7094132BD28Q34850830-401C2C40-6436-4CF0-9D48-4E9CD2EC5BD6Q35070227-A01A9F77-14BA-4D96-9C71-F418D027949FQ35088858-C35FB37A-08ED-4CFC-B221-47A43B243620Q35195525-77BE3EDC-0D49-44CE-A0A2-1AE9E103DAEFQ35196707-B88C5173-71F7-4826-BC59-30B9BF0456DFQ35200989-B093C9CB-3D29-453F-8DC4-622414253F72Q35205039-CFBB6DF7-5ABB-43CB-A810-942343F9A7C5Q35235496-381F0778-4029-4C6C-A6C4-D74C8A33BF3EQ35317556-B50BDCD2-A292-4A9F-8768-3B0CE0060FF9Q35560881-BD3C49FD-74F9-40ED-ABD8-51C62486A6B1Q35583311-81C8F9AE-8EAF-4ACA-BD0C-9603032EBB23Q35668366-F908F453-38C4-4906-9786-C3153B451204Q35674373-E874A446-4B01-4F6E-9445-15A9C7B66BA8Q35738812-DF9CFA07-85BF-4B0B-B8CB-4FA2F62AF96AQ35785178-57C527EB-B306-479B-8851-0959E15E3E85Q35798011-5D302A16-AE97-43C8-9BD8-35ED75766FE0Q35806742-8379540C-AFE2-468D-9BB9-6BC8A5878F60Q35812293-F832A93E-A2F9-4496-BE32-ECDC4845D93AQ36070138-FD30A92E-4FAA-4A95-9B26-4919412CB557Q36436653-55F112B4-709C-42FF-9CA1-46AD6FD48FA8Q36519047-103968E3-5189-4FD9-AB61-6BBC8B4CA757Q36537470-033438CF-FB8D-49B4-938B-B72A4081F7D8Q36576487-3AB73B1C-9478-49E4-99B0-77565631956FQ36589366-E381A5C4-0FC9-4D5D-A22F-BA2CEDF82BA1Q36589449-73CD205A-F6C2-423D-8155-F41F518438DCQ36609707-E3C780BC-1A38-463F-88A4-BDAE9CE21FEFQ36736281-C5FE88CF-21F4-420B-82C3-DD5193861F99
P2860
Using basic science to design a clinical trial: baseline characteristics of women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS)
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Using basic science to design ...... rogen Prevention Study (KEEPS)
@en
Using basic science to design ...... arly Estrogen Prevention Study
@nl
type
label
Using basic science to design ...... rogen Prevention Study (KEEPS)
@en
Using basic science to design ...... arly Estrogen Prevention Study
@nl
prefLabel
Using basic science to design ...... rogen Prevention Study (KEEPS)
@en
Using basic science to design ...... arly Estrogen Prevention Study
@nl
P2093
P2860
P1476
Using basic science to design ...... rogen Prevention Study (KEEPS)
@en
P2093
E A Brinton
F Naftolin
G R Merriam
H S Taylor
J E Manson
M I Cedars
M J Budoff
P2860
P2888
P304
P356
10.1007/S12265-009-9104-Y
P407
P577
2009-05-22T00:00:00Z